J
John A. Spertus
Researcher at University of Missouri–Kansas City
Publications - 1148
Citations - 62585
John A. Spertus is an academic researcher from University of Missouri–Kansas City. The author has contributed to research in topics: Myocardial infarction & Percutaneous coronary intervention. The author has an hindex of 56, co-authored 1017 publications receiving 51951 citations. Previous affiliations of John A. Spertus include American Heart Institute & Truman Medical Center.
Papers
More filters
Journal ArticleDOI
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons.
Stephan D. Fihn,Julius M. Gardin,Jonathan Abrams,Kathleen Berra,James C. Blankenship,Apostolos P. Dallas,Pamela S. Douglas,JoAnne M. Foody,Thomas C. Gerber,Alan L. Hinderliter,Spencer B. King,Paul Kligfield,Harlan M. Krumholz,Raymond Y. Kwong,Michael J. Lim,Jane A. Linderbaum,Michael J. Mack,Mark A. Munger,Richard L. Prager,Joseph F. Sabik,Leslee J. Shaw,Joanna D. Sikkema,Craig R. Smith,Sidney C. Smith,John A. Spertus,Sankey V. Williams +25 more
TL;DR: A Report of the American College of Cardiology Foundation/AmericanHeart Association Task Force on Practice Guidelines, and the AmericanCollege of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for CardiovascularAngiography and Interventions, and Society of ThorACic Surgeons
Journal ArticleDOI
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update A Guideline From the American Heart Association and American College of Cardiology Foundation
Sidney C. Smith,Emelia J. Benjamin,Robert O. Bonow,Lynne T. Braun,Mark A. Creager,Barry A. Franklin,Raymond J. Gibbons,Scott M. Grundy,Loren F. Hiratzka,Daniel W. Jones,Donald M. Lloyd-Jones,Margo Minissian,Lori Mosca,Eric D. Peterson,Ralph L. Sacco,John A. Spertus,James H. Stein,Kathryn A. Taubert +17 more
TL;DR: The development of the present guideline involved a process of partial adaptation of other guideline statements and reports and supplemental literature searches, which confirmed that in patients with atherosclerotic vascular disease, comprehensive risk factor management reduces risk as assessed by a variety of outcomes.
Journal ArticleDOI
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden Results From the Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation (COURAGE) Trial Nuclear Substudy
Leslee J. Shaw,Daniel S. Berman,David J. Maron,G.B. John Mancini,Sean W. Hayes,Pamela M. Hartigan,William S. Weintraub,Robert A. O'Rourke,Marcin Dada,John A. Spertus,Bernard R. Chaitman,John D. Friedman,Piotr J. Slomka,Gary V. Heller,Guido Germano,Gilbert Gosselin,Peter B. Berger,William J. Kostuk,Ronald G. Schwartz,Merill L Knudtson,Emir Veledar,Eric R. Bates,Benjamin D. McCallister,Koon K. Teo,William E. Boden +24 more
TL;DR: In COURAGE patients who underwent serial MPS, adding PCI to OMT resulted in greater reduction in ischemia compared with OMT alone, and the findings suggest a treatment target of ≥5% ischemic myocardium reduction with O MT with or without coronary revascularization.
Journal ArticleDOI
Initial invasive or conservative strategy for stable coronary disease.
David J. Maron,Judith S. Hochman,Harmony R. Reynolds,Sripal Bangalore,Sean M. O'Brien,William E. Boden,Bernard R. Chaitman,Roxy Senior,Roxy Senior,Jose Lopez-Sendon,Karen P. Alexander,Renato D. Lopes,Leslee J. Shaw,Jeffrey S. Berger,Jonathan D. Newman,Mandeep S. Sidhu,Shaun G. Goodman,Witold Rużyłło,Gilbert Gosselin,Aldo P. Maggioni,Harvey D. White,Balram Bhargava,James K. Min,G.B. John Mancini,Daniel S. Berman,Michael H. Picard,Raymond Y. Kwong,Ziad A. Ali,Ziad A. Ali,Daniel B. Mark,John A. Spertus,Mangalath Narayanan Krishnan,Ahmed Elghamaz,Nagaraja Moorthy,Whady Hueb,Marcin Demkow,Kreton Mavromatis,Kreton Mavromatis,Olga L. Bockeria,Jesús Peteiro,Todd D. Miller,Hanna Szwed,Rolf Doerr,Matyas Keltai,Joseph B. Selvanayagam,P. Gabriel Steg,Claes Held,Claes Held,Shun Kohsaka,Stavroula Mavromichalis,Ruth Kirby,Neal Jeffries,Frank E. Harrell,Frank W. Rockhold,Samuel Broderick,T. Bruce Ferguson,David O. Williams,Robert A. Harrington,Gregg W. Stone,Yves Rosenberg +59 more
TL;DR: Evidence that an initial invasive strategy, as compared with an initial conservative strategy, reduced the risk of ischemic cardiovascular events or death from any cause over a median of 3.2 years is not found.
Journal ArticleDOI
AHA/ACCF Secondary Prevention and Risk Reduction Therapy for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2011 Update
Sidney C. Smith,Emelia J. Benjamin,Robert O. Bonow,Lynne T. Braun,Mark A. Creager,Barry A. Franklin,Raymond J. Gibbons,Scott M. Grundy,Loren F. Hiratzka,Daniel W. Jones,Donald M. Lloyd-Jones,Margo Minissian,Lori Mosca,Eric D. Peterson,Ralph L. Sacco,John A. Spertus,James H. Stein,Kathryn A. Taubert +17 more
TL;DR: In this article, the authors present the 2006 update of the American Heart Association (AHA)/American College of Cardiology Foundation (ACCF) guidelines on secondary prevention and provide evidence from clinical trials that further supports and broadens the merits of intensive risk-reduction therapies for secondary prevention.